baber/WOPTO huggingface dataset:
Patent AU-2011202486-B2 (AU)
Title: Split non-pressurised solar water heating systems
Inventor: WU JIE QIN
IPC: F24D19/00
Filed: 2011-05-27
Granted: 2012-10-11
Abstract: Abstract The solar water heating system of the present invention comprises: (i) a heating unit adapted for heating of water therein by solar radiation, the heating unit having an inlet for receiving water for heating, and an outlet for discharge of heated water; (ii) a storage tank having an inlet for receiving water from the heating unit and an outlet for discharge andJor channelling of water to point of use, or for returning water to the heating unit; (iii) a delivery conduit for delivering water from the heating unit to the storage tank; (iv) a return conduit for returning water from the storage tank to the heating unit; (v) delivery and return valves for controlling flow of water through the delivery and return conduits respectively; (vi) at least one storage tank water temperature sensor; (vii) at least one heating unit water temperature sensor; (viii) an air inlet with air filter which allows filtered air to enter the storage tank; (ix) a control conduit for adding unheated potable water to the water being discharged from the storage tank, if necessary to lower its temperature to the required level; (x) a control valve to prevent any back-flow of water into the storage tank via its outlet; and (xi) a controller for controlling the flow of water through the delivery conduit, the return conduit and the control conduit, based on information provided by the storage tank water temperature sensor(s) and/or the heating unit water temperature sensor(s), by controlling operation of the delivery, return and control valves; whereby the controller ensures that only water having been heated to a specified minimum temperature flows from the heating unit to the storage tank; if the water temperature in the storage tank exceeds a specified maximum temperature, the controller operates the control valve in the control conduit to allow delivery of unheated potable water to the water discharging from the storage tank via its outlet; and the only in flows into the storage tank being (a) water having been heated in the heating unit to the specified minimum temperature or (b) filtered air.
Patent AU-2011203088-B2 (AU)
Title: Autofeed Screwdriving Tool
Inventor: PARK JEREMY SCOTT
IPC: B25B21/00
Filed: 2011-06-24
Granted: 2015-07-09
Abstract: A screwdriver for collated screws in which a tip of the screw projects forwardly of the tool prior to initiation of the screwdriving sequence and, preferably, a forwardly directed socket carried on a retractable nose portion engages the head of the screw 5 to be driven and urges the screw forwardly into a workpiece such that the pinching of the screw between the nose portion and the workpiece initiates retraction of the nose portion preferably leading to engagement of the screw by a rotating driver shaft.
Patent AU-2011208855-B2 (AU)
Title: Method and apparatus for detaching frozen charge from a tube mill
Inventor: KELLER ROBERT
IPC: B02C25/00
Filed: 2011-01-14
Granted: 2013-09-05
Abstract: A method and associated apparatus for detaching a frozen charge (14) from an inner wall (12) of a grinding pipe (10) of a tube mill such as is used for grinding. The method comprising the steps of controlling a driving device of the grinding pipe (10) to detach a frozen charge (14) from an inner wall (12) of the grinding pipe (10), which driving device is operable to apply a driving torque to the grinding pipe (10), wherein controlling the driving device comprises varying the driving torque applied to the grinding pipe (10) around a predetermined reference level.
Patent AU-2011213944-B2 (AU)
Title: Salts and polymorphs of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one
Inventor: BASFORD PATRICIA ANN
IPC: C07D487/06
Filed: 2011-02-10
Granted: 2014-10-02
Abstract: The present invention relates to novel polymorphic forms of 8-fluoro-2-{4- [(methylamino)methyl]phenyf}-1,3,4,5-tetrahydro-6H-azepino(5,4,3-cd]indol-6-one;(I), and to processes for their preparation. Such polymorphic forms may be a component of a pharmaceutical composition and may be used to treat a mammalian disease condition mediated by poly(ADP-ribose) polymerase activity including the disease condition such as cancer.
Patent AU-2011223977-B2 (AU)
Title: Location-based services
Inventor: BURGISS MICHAEL J
IPC: H04M3/493
Filed: 2011-09-12
Granted: 2012-12-20
Abstract: A method for tracking purchases in a location-based services system, including the steps of said location-based services system receiving a remote terminal identifier and a geographic indicator from a remote 5 terminal, said location-based services system receiving a request, wherein said request is for information on a particular product from a consumer using said remote terminal, said location-based services system processing said request to identify consumer specified geographic information included in said request, said location-based services system determining that said 10 consumer specified geographic information is not present in said request, said location-based services system defaulting to a current geographic location of said remote terminal based on said remote terminal identifier and said geographic indicator, and identifying a business located within a geographic region that is defined by said current geographic location, 15 generating, with said location-based services system responsive to said request, an offer identifier, associating said offer identifier with a respective offer from said identified business, generating a geographically tailored response to said request with said location-based services system that includes said respective offer and said offer identifier, displaying said 20 respective offer and said offer identifier to said consumer with said location-based services system based on said geographically tailored response, said location-based services system receiving an acceptance of said respective offer by said consumer, and in response to said acceptance, said location-based services system storing said respective offer, said offer identifier, and said acceptance of said respective offer in a personal list associated with said consumer, and in a database that is associated with said business. WO 02/088880 PCT/US02/13243 cz F - - - - - - - - - - - - - - O:f CIA L-1 Ck- cm m M cm cn LO to V) CD co C%4 C:) : F -d Q) C> F-- ck..: co tn CD CD cm C> Cl- LO w L j V) C:) O f CD w Ckf ca- "It ck, L-j > LJ L-J c:) c> CL Q:f O!f w L C-> Ckf cn Ck- L-i =) <D Lr) Lo V) tn CLLLJ V) Q:: W LJ CN S2 :c >. ck- V) LAJ V) C-4 C: w LLJ :z:: C) LA-1 F- LAJ C-) Cl- LAJ C) C"4 Ck:: C) w >< Lj Lai m ;M C/) rc 00 Q cl El Q:: C-> s - (N m tn C"14 m - -7 m =:) LLJ LLJ ul) Ck'-' C--) "I >- '-' :Z: F-- I C:) C-- -.Ct Ck:f - -< 5. C/) ti- , CL- 33:: C> -- F c)::: cl-- -d*-I -C:C Coe) 01-1 C--> L J w C..) C-D Cl- C/I cn LAJ CD -- c (/-) L j CL- i:: !22 C) Ck= -T - - - m V) LO cn 'Tt m => C> LLJ V) 0666 N 3:
Patent AU-2011226946-B2 (AU)
Title: Caspase Inhibitors and Uses Thereof
Inventor: CHARRIER JEAN-DAMIEN
IPC: C07D405/12
Filed: 2011-09-29
Granted: 2012-05-03
Abstract: The present invention provides a compound of formula I: R, N A 11, wherein the variables are as defined herein. The present invention also provides processes for preparing the compounds of formula I, and intermediates thereof, pharmaceutical compositions comprising those compounds, and methods of using the compounds and compositions.
Patent AU-2011248657-B2 (AU)
Title: Transcatheter prosthetic heart valve delivery device with passive trigger release
Inventor: DWORK JOSHUA
IPC: A61F2/24
Filed: 2011-04-27
Granted: 2014-12-04
Abstract: A delivery device (50) for percutaneously deploying a prosthetic valve (20) includes a sheath (52), an inner shaft (54), and a release assembly (56). The release assembly is disposed between the sheath and the inner shaft, and includes a retraction member (142), a release member (144), and a retention member (146). The retraction member can self-retract in length from an extended condition to a retracted condition. The release member can self-expand from a compressed condition to an expanded condition. The retention member is distal the release member. In a delivery state, the sheath end is distal the retention member, the release member is in the compressed condition and the retraction member in the extended condition to retain the prosthesis. In a deployment state, the sheath end is positioned to permit the release member to self-transition to the expanded condition, allowing the retraction member to self-transition to the retracted condition and release the prosthesis.
Patent AU-2011275260-B2 (AU)
Title: Disposable diaper
Inventor: TAKAHASHI YUKI
IPC: A61F13/15
Filed: 2011-06-20
Granted: 2014-02-13
Abstract: A pants -type disposable diaper has an outer covering sheet formed of a nonwoven fabric. An absorbent body is attached on the outer covering sheet to absorb excrement from the wearer. Sheet members are bonded, (also called "end sheets" or "end holding sheets") on the front and back, each end portion of the absorbent body being positioned and fixed between the sheet member and the outer covering sheet. The sheet member may be a laminated sheet of plastic film and nonwoven fabric, stretching of the sheet member is suppressed and it is possible to easily bring the absorbent body in close contact with the crotch region of the wearer when putting the disposable diaper on the wearer. The sheet member may also be formed of nonwoven fabric, a fiber orientation of nonwoven fabric on the sheet member then being orthogonal to the edges of end portions of the outer covering sheet in the longitudinal direction, to suppress longitudinal streching of the sheet member.
Patent AU-2011288402-B2 (AU)
Title: Coding system for a drug delivery device and drug delivery system
Inventor: AVERY RICHARD JAMES VINCENT
IPC: A61M5/315
Filed: 2011-08-11
Granted: 2014-07-03
Abstract: A coding system for a drug reservoir (200), where the drug reservoir is intended for use with a reservoir holder (212) of a drug delivery device. The coding system includes a collar (202) fitted around the drug reservoir. The collar includes a coding feature (208, 208a, 208b) that is configured to pass through a corresponding coding feature (210, 210a, 210b) provided by the reservoir holder of the drug delivery device.
Patent AU-2011299918-B2 (AU)
Title: Magnesium recovery method and magnesium recovery apparatus
Inventor: IWAMOTO TATSUSHI
IPC: C25B11/06
Filed: 2011-09-06
Granted: 2014-09-04
Abstract: In this magnesium recovery method and this magnesium recovery apparatus, anodically electrolyzed water (7a) and cathodically electrolyzed water (7b) both generated by the electrolysis of seawater are separated from each other, an alkaline material is introduced into the anodically electrolyzed water to adjust the pH value of the anodically electrolyzed water, magnesium is allowed to precipitate in the cathodically electrolyzed water in the form of magnesium hydroxide and is then recovered, the pH-adjusted anodically electrolyzed water and the cathodically electrolyzed water after the fixing of a carbonate salt are joined together, and the joined solution is adjusted to the same pH value as that of seawater and is then discharged. In this manner, magnesium can be recovered from seawater while minimizing an environmental load.
Patent AU-2011328285-B2 (AU)
Title: Method for operation of a photovoltaic installation for feeding electrical power into a medium-voltage power supply grid
Inventor: FALK ANDREAS
IPC: H01L31/042
Filed: 2011-11-04
Granted: 2015-05-28
Abstract: The invention relates to a method for operation of a photovoltaic installation for feeding electrical power into a medium-voltage power supply grid (41), with the photovoltaic installation having a multiplicity of photovoltaic modules (11), at least one inverter (21) and at least one medium-voltage transformer (31), and with the primary side of the medium-voltage transformer (31) being connected directly to an alternating-current (AC) low-voltage output (24) of the inverter (21), and at least one direct-current (DC) switching member (12) being arranged between the photovoltaic modules (11) and a DC input (22) of the inverter (21). The method is distinguished in that when the electrical power produced by the photovoltaic modules (11) in the photovoltaic installation is not sufficient for feeding electrical power into the supply grid (41), the photovoltaic modules (11) are disconnected from an inverter (21) on the DC voltage side while, in contrast, the inverter (21) remains connected to the medium-voltage power supply grid (41) on the AC voltage side by the medium-voltage transformer (31). The invention also relates to a photovoltaic installation which is designed to carry out the method.
Patent AU-2011328535-B2 (AU)
Title: Forward osmosis system having solvent separation by means of membrane distillation
Inventor: HEINZL WOLFGANG
IPC: B01D61/00
Filed: 2011-10-06
Granted: 2017-05-04
Abstract: The invention relates to a system for separating a product contained as solvent in a solution to be processed, comprising at least one forward osmosis device (816) through which the solution to be processed and a draw solution flow, and a device connected downstream thereof for obtaining the product (56, 62) from the diluted draw solution exiting the forward osmosis device, wherein the forward osmosis device comprises at least one flow channel conducting the solution to be processed and at least one flow channel conducting the draw solution, the inner space of a respective flow channel conducting the solution to be processed is delimited at least partially by a semi-permeable membrane wall that is permeable to the solvent of the solution to be processed but not to the substance dissolved therein, and at least one flow channel conducting the draw solution is delimited on opposite sides by membrane walls that are associated with two adjoining flow channels conducting the solution to be processed, such that solvent from the solution to be processed passes through the membrane walls into the adjoining flow channels conducting the draw solution.
Patent AU-2011331103-B2 (AU)
Title: Inhibitors of apoptosis and uses thereof
Inventor: BARRERE STEPHANIE
IPC: C07K14/47
Filed: 2011-11-17
Granted: 2016-11-24
Abstract: The invention relates to fragments of the DAXX and FADD proteins that inhibit cell apoptosis, in particular cell apoptosis mediated by the Fas receptor. The invention also relates to derivatives of said anti-apoptotic fragments, conjugates comprising said fragments, pharmaceutical compositions comprising said fragments, and to the medical applications of said fragments, derivatives, conjugates, and pharmaceutical compositions thereof in the treatment or prevention of diseases and conditions associated with apoptosis.
Patent AU-2011375763-B2 (AU)
Title: Downhole fluid flow control system and method having dynamic response to local well conditions
Inventor: GANO JOHN CHARLES
IPC: E21B21/08
Filed: 2011-08-29
Granted: 2015-06-25
Abstract: A downhole fluid flow control system having dynamic response to local well conditions. The system includes a tubing string operably positionable in a wellbore. Annular barriers are positioned between the tubing string and the wellbore to isolate first and second zones. A fluid flow control device is positioned within each zone. A flow tube that is operably associated with the fluid flow control device of the first zone is operable to establish communication between the second zone and the fluid flow control device in the first zone such that a differential pressure between the first zone and the second zone is operable to actuate the fluid flow control device of the first zone from a first operating configuration to a second operating configuration.
Patent AU-2012213926-B2 (AU)
Title: Spinach hybrid RX 06661505 and parents thereof
Inventor: BAERENDS BERNARDUS
IPC: A01H4/00
Filed: 2012-08-14
Granted: 2015-03-12
Abstract: [0089] The invention provides seed and plants of spinach hybrid RX 06661505 and the parent lines thereof. The invention thus relates to the plants, seeds and tissue cultures of spinach hybrid RX 06661505 and the parent lines thereof, and to methods for producing a spinach plant produced by crossing such plants with themselves or with another spinach plant, such as a plant of another genotype. The invention further relates to seeds and plants produced by such crossing. The invention further relates to parts of such plants, including the leaf and gametes of such plants. -32-
Patent AU-2012230042-B2 (AU)
Title: Surgical instruments with lockable articulating end effector
Inventor: SCHUCKMANN JOHN C
IPC: A61B17/29
Filed: 2012-03-13
Granted: 2016-03-31
Abstract: Hand-held surgical instruments that have and end effector attached to an elongate shaft are disclosed. The end effector has at least a portion that is movable in response to opening and closing motions applied thereto by a closure member. An articulation control system is provided to articulate the end effector relative to the shaft. An articulation locking system is provided to lock the end effector in a desired articulated position. The locking system interfaces with the closure member and is activated upon application of a closure motion to the end effector.
Patent AU-2012232934-B2 (AU)
Title: Topical sunscreen compositions
Inventor: DALY SUSAN
IPC: A61K8/35
Filed: 2012-09-27
Granted: 2015-07-09
Abstract: Substantially anhydrous compositions including at least 10% by weight of a C2 or C3 mono-alcohol, a solid, organic UV-filter dissolved therein; and an oil portion including one or more oils, the oil portion having an interfacial tension with water of greater than 9 and less than 13.9. The composition has a volume fraction of oil portion relative to the 5 sum of the oil portion plus C2 or C3 mono alcohol that is greater than 0.091.
Patent AU-2012238336-B2 (AU)
Title: MicroRNA-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer
Inventor: CROCE CARLO M
IPC: A61K38/00
Filed: 2012-10-11
Granted: 2014-04-10
Abstract: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER The present invention provides novel methods and compositions for the diagnosis, prognosis and treatment of lung cancer. The invention also provides methods of identifying anti-lung cancer agents.
Patent AU-2012241778-B2 (AU)
Title: Measuring system and method for determining new points
Inventor: METZLER BERNHARD
IPC: G01C15/00
Filed: 2012-04-13
Granted: 2014-08-07
Abstract: The invention relates to a geodetic measuring system having at least one reference component which defines a reference point, wherein an absolute position of the reference point is known, and at least one new-point determination component (31) which derives a relative new-point position (2). It is also possible to derive mutual relative reference information between the reference component and the new-point determination component, in particular for the purpose of referencing with respect to the reference-point position. The measuring system (1) also has an automotive, unmanned, controllable air vehicle, wherein the air vehicle (50) has the reference component which provides the at least one reference point as a mobile reference point. The air vehicle (50) is also designed in such a manner that the reference component can be spatially freely displaced by the air vehicle (50), in particular can be positioned in a substantially fixed position.
Patent AU-2012275295-B2 (AU)
Title: WAP domain fusion polypeptides and methods of use thereof
Inventor: TIMMER JOHN C
IPC: A61K39/395
Filed: 2012-06-28
Granted: 2016-11-10
Abstract: This invention relates to fusion proteins that include a whey acidic protein (WAP) domain-containing polypeptide and a second polypeptide. Additionally, the invention relates to fusion proteins that include a WAP domain-containing polypeptide, a second polypeptide, and a third polypeptide. The second and/or third polypeptides of the fusion proteins of the invention are an Fc polypeptide; an albumin polypeptide; a cytokine targeting polypeptide; or a serpin polypeptide. This invention also relates to methods of using such molecules in a variety of therapeutic and diagnostic indications, as well as methods of producing such molecules.
Patent AU-2012295410-B2 (AU)
Title: Process for the manufacturing of sevoflurane
Inventor: KUDZMA LINAS
IPC: C07C41/22
Filed: 2012-08-03
Granted: 2014-10-30
Abstract: The present invention provides a method for forming sevoflurane comprising (i) combining chlorosevo ether, a nucleophilic fluoride reagent, and a solvent comprising sevoflurane to form an initial reaction mixture and (ii) reacting the initial reaction mixture to form additional sevoflurane relative to the amount of sevoflurane present in the initial reaction mixture. The present disclosure is also directed to a method for forming sevoflurane, comprising: initiating a reaction between chlorosevo ether and a nucleophilic fluoride reagent in an initial reaction mixture further comprising a solvent comprising sevoflurane, thereby forming additional sevoflurane relative to the amount of sevoflurane present in the initial reaction mixture.
Patent AU-2012306422-B2 (AU)
Title: Amino-substituted imidazopyridazines
Inventor: EIS KNUT
IPC: A61K31/5025
Filed: 2012-09-05
Granted: 2017-10-26
Abstract: The present invention relates to amino-substituted imidazopyridazine compounds of general formula(I): in which A, R1, R3 and n are as defined in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.
Patent AU-2012307524-B2 (AU)
Title: Use of omega fatty acids for treating disease
Inventor: GEORGIOU TASSOS
IPC: A61K31/202
Filed: 2012-09-12
Granted: 2016-10-20
Abstract: Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), or a salt or an ester thereof, are provided for use in the treatment and/or prophylaxis of a condition selected from macular oedema, conditions causing damage to retinal photoreceptors and/or retinal pigment epithelial cells, and dry eyes in a mammal, wherein the combined dosage of eicosapentaenoic acid and docosahexaenoic acid is from 5 mmol to 25 mmol per day, and wherein the molar ratio of eicosapentaenoic acid to docosahexaenoic acid is in the range of from 1:1 to 5: 1. Compositions comprising EPA and DHA and at least one pharmaceutically acceptable excipient, and kits containing EPA, DHA and further therapeutic agents are also provided. The EPA and DHA, or composition comprising the EPA and DHA may be administered orally.
Patent AU-2012331281-B2 (AU)
Title: 5-phenyl-substituted N-(tetrazol-5-yl) aryl carboxylic acid amides and N-(triazol-5-yl) aryl carboxylic acid amides, and use thereof as herbicides
Inventor: BRAUN RALF
IPC: C07D257/06
Filed: 2012-10-29
Granted: 2017-06-15
Abstract: The invention relates to 5-phenyl-substituted N-(tetrazol-5-yl) aryl carboxylic acid amides and N-(triazol-5-yl) aryl carboxylic acid amides of general formula (I) as herbicides. In said formula (I), W, X, Y, Z, and R stand for groups such as hydrogen, organic groups such as alkyl, and other groups such as halogen. A and B stand for N and CY.